Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. — Natural Product Compound Library | Innovative Drug Discovery | Spectral Intelligence | Micro-ED Analysis

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. Healthy Roots Biotechnology (Shenzhen) Co., Limited Joint Development

中文 EN

Home

Products

NP Database

Services

Tech Insights

About

Contact

中文 EN

Plant Sources

Structural Classes

Microbial Sources

Flagship Varieties

Synthetic Compounds

CAS No.	NAME	Molecular Formula	Molecular Weight	Purity	Price	2D Structure
168180-12-9	Phyllanthurinolactone C1C(C=CC2=CC(=O)OC21)OC3C(C(C(C(O3)CO)O)O)O	C₁₄H₁₈O₈	314.29	97%	Click to inquire
170384-81-3	Zedoalactone B CC1=C2CC3C(CCC3(C(C=C2OC1=O)(C)O)O)(C)O	C₁₅H₂₀O₅	280.32	98%	Click to inquire
17398-06-0	Umtatin CC(=C)C1CC2=C(O1)C=C3C(=C2O)C(=O)C=C(O3)CO	C₁₅H₁₄O₅	274.27	98%	Click to inquire
176050-48-9	Zerumin A CC1(CCCC2(C1CCC(=C)C2CC=C(CC(=O)O)C=O)C)C	C₂₀H₃₀O₃	318.4	97.5%	Click to inquire
176050-49-0	zerumin B CC1(CCCC2(C1CCC(=C)C2CC(C3=CC(OC3=O)O)O)C)C	C₂₀H₃₀O₄	334.4	98%	Click to inquire
18104-24-0	Porphyroxine COC1C2=C(C=CC3=C2OCO3)C4C(O1)C5=CC(=C(C=C5CCN4)OC)O	C₂₀H₂₁NO₆	371.4	97.5%	Click to inquire
18145-26-1	Acutumidine COC1=CC(=O)C2(C1O)C(CC34C2(CCN3)CC(=O)C(=C4OC)OC)Cl	C₁₈H₂₂ClNO₆	383.8	98%	Click to inquire
184686-01-9	(2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5R,6R)-3,5-dihydroxy-2-[(1R,2S,4S,5'S,6R,7S,8R,9S,12S,13R,16S,18S,19S)-16-hydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-19-yl]oxy-6-methyloxan-4-yl]oxy-6-methyloxane-3,4,5-triol CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC(C6C5(CCC(C6)O)C)OC7C(C(C(C(O7)C)O)OC8C(C(C(C(O8)C)O)O)O)O)C)C)OC1	C₃₉H₆₄O₁₂	724.9	96.5%	Click to inquire
184686-02-0	(2S,3R,4S,5R)-2-[(2R,3R,4S,5R,6R)-3,5-dihydroxy-2-[(1R,2S,4S,5'S,6R,7S,8R,9S,12S,13R,16S,18S,19S)-16-hydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-19-yl]oxy-6-methyloxan-4-yl]oxyoxane-3,4,5-triol CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC(C6C5(CCC(C6)O)C)OC7C(C(C(C(O7)C)O)OC8C(C(C(CO8)O)O)O)O)C)C)OC1	C₃₈H₆₂O₁₂	710.9	97%	Click to inquire
184686-03-1	(1R,2S,4S,5'S,6R,7S,8R,9S,12S,13R,18S,19S)-5',7,9,13-tetramethyl-19-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16-one CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC(C6C5(CCC(=O)C6)C)OC7C(C(C(C(O7)C)O)O)O)C)C)OC1	C₃₃H₅₂O₈	576.8	93%	Click to inquire

Phyllanthurinolactone

Phyllanthurinolactone

C₁₄H₁₈O₈ 314.29

C₁₅H₂₀O₅ 280.32

C₁₅H₁₄O₅ 274.27

C₂₀H₃₀O₃ 318.4

C₂₀H₃₀O₄ 334.4

C₂₀H₂₁NO₆ 371.4

C₁₈H₂₂ClNO₆ 383.8

(2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5R,6R)-3,5-dihydroxy-2-[(1R,2S,4S,5'S,6R,7S,8R,9S,12S,13R,16S,18S,19S)-16-hydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-19-yl]oxy-6-methyloxan-4-yl]oxy-6-methyloxane-3,4,5-triol

Neochlorogenin 6-O-α-L-rhamnopyranosyl-(1→3)-β-D-quinovopyranoside

C₃₉H₆₄O₁₂ 724.9

(2S,3R,4S,5R)-2-[(2R,3R,4S,5R,6R)-3,5-dihydroxy-2-[(1R,2S,4S,5'S,6R,7S,8R,9S,12S,13R,16S,18S,19S)-16-hydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-19-yl]oxy-6-methyloxan-4-yl]oxyoxane-3,4,5-triol

Neochlorogenin 6-O-β-D-xylopyranosyl-(1→3)-β-D-quinovopyranoside

C₃₈H₆₂O₁₂ 710.9

(1R,2S,4S,5'S,6R,7S,8R,9S,12S,13R,18S,19S)-5',7,9,13-tetramethyl-19-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16-one

Solagenin 6-O-β-D-quinovopyranoside

C₃₃H₅₂O₈ 576.8

< Previous 1 2 3 4 5 6 7 8 9 10 ... (Current page 16050) 16106 Next >

All products and services are for scientific research only. They may not be used for human administration, nor are they supplied to individual consumers.

Address: Room B410, Virtual University Park Key Laboratory Building, No. 1 Yuexing 2nd Road, High-Tech Zone Community, Yuehai Subdistrict, Nanshan District, Shenzhen

Phone: 400-856-5689

Email: kehuaai@kehuaai.com

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd.

ICP Record No.: 粤ICP备2024241782号